GE HealthCare Technologies Price to Sales Ratio 2020-2024 | GEHC
Historical PS ratio values for GE HealthCare Technologies (GEHC) over the last 10 years. The current P/S ratio for GE HealthCare Technologies as of September 16, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| GE HealthCare Technologies P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-09-17 | 86.79 | 2.04 | |
| 2024-06-30 | 77.92 | $42.57 | 1.83 |
| 2024-03-31 | 90.91 | $42.54 | 2.14 |
| 2023-12-31 | 77.32 | $42.71 | 1.81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $39.565B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $8.437B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.201B | 1155.17 |
| Axonics (AXNX) | United States | $3.528B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.497B | 203.50 |
| 10x Genomics (TXG) | United States | $2.593B | 0.00 |
| Enovis (ENOV) | United States | $2.373B | 17.20 |
| Azenta (AZTA) | United States | $2.350B | 133.44 |
| IRhythm Technologies (IRTC) | United States | $2.302B | 0.00 |
| Privia Health (PRVA) | United States | $2.235B | 155.75 |
| Omnicell (OMCL) | United States | $2.064B | 67.99 |
| Clover Health Investments (CLOV) | United States | $1.522B | 0.00 |
| Schrodinger (SDGR) | United States | $1.446B | 0.00 |
| Phreesia (PHR) | United States | $1.413B | 0.00 |
| Standard BioTools (LAB) | United States | $0.776B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.670B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.524B | 444.00 |
| Health Catalyst (HCAT) | United States | $0.515B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.389B | 0.00 |
| Talkspace (TALK) | United States | $0.321B | 0.00 |
| Pulmonx (LUNG) | United States | $0.319B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.261B | 0.00 |
| TruBridge (TBRG) | United States | $0.187B | 13.70 |
| P3 Health Partners (PIII) | United States | $0.178B | 0.00 |
| American Well (AMWL) | United States | $0.143B | 0.00 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.075B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| 111 (YI) | China | $0.048B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.033B | 0.00 |
| Outset Medical (OM) | United States | $0.027B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.025B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |